RxDoctor Payments Data

Robert Nicholas, MD

Otolaryngology · Yankton, SDNPI 1609221563

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.5%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Medical Device Business Services, Inc. at 55.6% of the total. Reporting peaked in 2022 at $837 and has fallen 93.2% since, to $57 in 2025. That places this record below the midpoint for otolaryngology clinicians in SD, where the typical reported total is $1,076.

$1,192in general payments, 2019–2025

Across 27 payments — averaging $44.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$663
  • Regeneron Healthcare Solutions, Inc.$218
  • Acclarent, Inc$108
  • Sanofi$71
  • Cochlear Americas$70
  • Advanced Bionics, LLC$26
  • plus $35 from 2 others

What the payments were for

  • Travel & lodging$56347%
  • Food & beverage$62652%
  • Gifts$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,192 in reported general payments places this provider in the 50th percentile of 39 otolaryngology providers in South Dakota.

See all otolaryngology providers in South Dakota

Medicare billing

Part B allowed, 2024
$117,501
Medicare patients
434
Services billed
1,116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab14$51,791
Azelastine Hcl230$5,336
Ipratropium Bromide129$3,360
Fluticasone Propionate170$2,082
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth12$1,545
CefuroximeCefuroxime Axetil14$369
Ciprofloxacin Hcl37$335
Omeprazole35$187
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$177
Montelukast Sodium45$149
Famotidine49$141
Mupirocin19$104
Methylprednisolone12$78
Prednisone13$59
Hydrocortisone12$47

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Yankton

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →